<DOC>
	<DOCNO>NCT01318369</DOCNO>
	<brief_summary>The main goal trial study efficacy Namisol® single dose Δ9-THC treatment pain result chronic pancreatitis . Objective measure pain processing , e.g . encephalography ( EEG ) quantitative sensory testing ( QST ) , include provide insight underlie nociceptive processing .</brief_summary>
	<brief_title>Efficacy Study Δ9-THC Treat Chronic Abdominal Pain</brief_title>
	<detailed_description>The important symptom chronic pancreatitis ( CP ) abdominal pain . Pancreatic pain often recurrent , intense long-lasting , extremely difficult treat . Medical analgesic therapy consider first choice pain management CP , result regularly prescription opioids . The adverse consequence prolong opioid use , include addiction , tolerance opioid induce hyperalgesia , call alternative medical treatment . Cannabis use treat pain many century . Delta-9-tetrahydrocannabinol ( Δ9-THC ) , psychoactive substance cannabis plant , show previous study promise analgesic . The development Namisol® , tablet contain purify Δ9-THC showing improve reliable pharmacokinetic profile , provide opportunity test analgesic potential Δ9-THC favourable condition .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>Patient chronic pancreatitis , diagnose use Marseille Cambridge Classification System ( addendum II ) .37 Patient suffers chronic abdominal pain typical pancreatitis , meet criterion chronic pain accord ISAP ( intermittent persistent pain daily basis least 3 month ) 38 , consider pain must severe enough medical treatment ( average NRS ≥ 3 ) . Patient opioid group take stable dos opioids , e.g . morphine tramadol , past 2 month day screen . Stable dose intake define daily equivalent sum opioid intake accord medical prescription within small deviation range judge ( principal ) investigator . Patient nonopioid group take opioids past 2 month day screen . Patient use cannabinoid ( smoke cannabis oral intake ) least one year day screen . Patient feel pinprick test low extremity , due affect sensory input ( e.g . neuropathy result diabetes mellitus ) . Patient body mass index ( BMI ) 18 31.2 kg/m2 . Patient suffers serious painful condition chronic pancreatitis major preexist chronic pain syndrome . Patient ( history ) significant medical disorder , opinion investigator , may interfere study may pose risk patient . Patient us kind concomitant medication , opinion investigator , may interfere study may pose risk patient ( e.g . HIV antiviral ) . Patient take amitriptyline daily basis . Patient take 20 mg benzodiazepine 6 hour prior follow intake study medication ( 11 hour ) accord prescription .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>